Handelsbanken Fonder’s bluebird bio BLUE Stock Holding History

Handelsbanken Fonder’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-643	Closed	-$266K	–	1678
2021 Q2	$266K	Sell	643 -324	-34%	-$128K	﹤0.01%	1656
2021 Q1	$378K	Hold	967	–	–	﹤0.01%	1339
2020 Q4	$542K	Hold	967	–	–	﹤0.01%	1117
2020 Q3	$676K	Buy	967 +154	+19%	+$120K	0.01%	853
2020 Q2	$643K	Buy	+813	New	+$613K	0.01%	843

Other funds holding BLUE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Handelsbanken Fonder's BLUE Position: Q3 2021 in Review

Handelsbanken Fonder sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 643 shares — an estimated $266K sold.

Handelsbanken Fonder first reported a position in BLUE in Q2 2020 and held it in 5 quarters. The position peaked at $676K in Q3 2020. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.

Handelsbanken Fonder reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
Handelsbanken Fonder sold 643 bluebird bio shares in Q3 2021, an estimated $266K.
Handelsbanken Fonder first reported a position in bluebird bio in Q2 2020 and held it in 5 quarters.
Handelsbanken Fonder's bluebird bio position peaked at $676K in Q3 2020.
196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.

Based on Handelsbanken Fonder's 13F filing for Q3 2021, filed 10 Nov 2021.